Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hep B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04248426
What this trial is testing

Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Antios Therapeutics, Inc 88
Post-approval studies (Phase 4)Study completedNCT05753280
What this trial is testing

Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHB

Who this might be right for
Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University 90
Testing effectiveness (Phase 2)Study completedNCT02726789
What this trial is testing

Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 5
Not applicableStudy completedNCT05317260
What this trial is testing

Steatohepatitis in Chronic Hepatitis B

Who this might be right for
Fatty LiverChronic Hepatitis b
Mahidol University 408
Post-approval studies (Phase 4)Study completedNCT03471624
What this trial is testing

Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)

Who this might be right for
Hepatitis B, Chronic
Stanford University 270
Post-approval studies (Phase 4)UnknownNCT00921180
What this trial is testing

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
National Taiwan University Hospital 148
Testing effectiveness (Phase 2)Study completedNCT01204762
What this trial is testing

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Who this might be right for
Hepatitis B Virus
Bristol-Myers Squibb 197
Post-approval studies (Phase 4)UnknownNCT03801538
What this trial is testing

The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Testing effectiveness (Phase 2)Study completedNCT04856085
What this trial is testing

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Vir Biotechnology, Inc. 244
Not applicableNot Yet RecruitingNCT07053449
What this trial is testing

The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms

Who this might be right for
Hepatitis B Virus (HBV)
Nottingham University Hospitals NHS Trust 30
Early research (Phase 1)Not Yet RecruitingNCT07589400
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver DiseaseChronic Hepatitis b
Xiamen Amoytop Biotech Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT02888106
What this trial is testing

Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent

Who this might be right for
Chronic Viral Hepatitis B With Delta-agent
Hepatera Ltd. 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT07135349
What this trial is testing

A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B

Who this might be right for
Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd. 209
Testing effectiveness (Phase 2)Study completedNCT02366208
What this trial is testing

Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Jiangsu Hansoh Pharmaceutical Co., Ltd. 116
Post-approval studies (Phase 4)UnknownNCT01834508
What this trial is testing

3E Extension Study

Who this might be right for
Chronic Hepatitis B
Nanfang Hospital, Southern Medical University 600
Not applicableUnknownNCT02589652
What this trial is testing

Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 294
Not applicableStudy completedNCT05871749
What this trial is testing

Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B

Who this might be right for
Hepatic SteatosisHepatic FibrosisChronic Hepatitis b
So Yeon Kim 120
Testing effectiveness (Phase 2)Looking for participantsNCT05771402
What this trial is testing

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)

Who this might be right for
Chronic Hepatitis bAnti-PD-1 AntibodyPeg-IFNα
The Second Affiliated Hospital of Chongqing Medical University 120
Post-approval studies (Phase 4)Study completedNCT06000657
What this trial is testing

Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir

Who this might be right for
Hepatitis B, Chronic
Daewoong Pharmaceutical Co. LTD. 196
Post-approval studies (Phase 4)Study completedNCT00625339
What this trial is testing

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA

Who this might be right for
Hepatitis B, Chronic
Yonsei University 72
Next Page